EDA2R
Tumor necrosis factor receptor superfamily member 27
Also known as: EDA-A2R, EDAA2R, TNFRSF27, TNR27_HUMAN, XEDAR
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HAV5
- Gene
- EDA2R
- Ensembl
- ENSG00000131080
- Chromosome
- X
- Canonical length
- 297 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Cell Junctions
OverviewNCBI Gene
The protein encoded by this gene is a type III transmembrane protein of the TNFR (tumor necrosis factor receptor) superfamily, and contains cysteine-rich repeats and a single transmembrane domain. This protein binds to the EDA-A2 isoform of ectodysplasin, which plays an important role in maintenance of hair and teeth. Alternatively spliced transcript variants encodes distinct protein isoforms. [provided by RefSeq, Apr 2016]
Canonical amino-acid sequenceUniProt
297 residues, UniProt reviewed canonical sequence.
>Q9HAV5|EDA2R
1 MDCQENEYWD QWGRCVTCQR CGPGQELSKD CGYGEGGDAY CTACPPRRYK SSWGHHRCQS
61 CITCAVINRV QKVNCTATSN AVCGDCLPRF YRKTRIGGLQ DQECIPCTKQ TPTSEVQCAF
121 QLSLVEADTP TVPPQEATLV ALVSSLLVVF TLAFLGLFFL YCKQFFNRHC QRGGLLQFEA
181 DKTAKEESLF PVPPSKETSA ESQVSENIFQ TQPLNPILED DCSSTSGFPT QESFTMASCT
241 SESHSHWVHS PIECTELDLQ KFSSSASYTG AETLGGNTVE STGDRLELNV PFEVPSPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EDA2R can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 7.7 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 7.7 nTPM
- ovary: 5.7 nTPM
- adrenal gland: 5.5 nTPM
- cervix: 5.4 nTPM
- endometrium: 5.3 nTPM
- thyroid gland: 5.3 nTPM
Single-cell type
- thymic myoid cells: 33 nCPM
- microglia: 21 nCPM
- choroid plexus epithelial cells: 14 nCPM
- medullary thymic epithelial cells: 12 nCPM
- myonuclei: 11 nCPM
- pituitary stem cells: 9.5 nCPM
Immune cell
- memory CD4 T-cell: 0.1 nTPM
- naive B-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- choroid plexus: 6.8 nTPM
- white matter: 6.7 nTPM
- pons: 4.7 nTPM
- medulla oblongata: 4.6 nTPM
- basal ganglia: 4 nTPM
- cerebral cortex: 3.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about EDA2R.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 69 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.34
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.21
- DepMap mean gene effect
- 0.15
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cytokine-mediated signaling pathway
- ectodermal cell differentiation
- epidermis development
- intrinsic apoptotic signaling pathway by p53 class mediator
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of JNK cascade
Molecular functions
- signaling receptor activity
- transmembrane signaling receptor activity
- tumor necrosis factor receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- TNFR/NGFR cysteine-rich region
- Tumor necrosis factor receptor superfamily member 19/27/EDAR
- TNFR/NGFR cysteine-rich region
- Tumour necrosis factor receptor 27
- Tumor necrosis factor receptor 27, N-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EDA2R in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EDA2R as an antibody target. Whether an autoantibody or antibody against EDA2R could matter depends on whether native EDA2R is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EDA2R is annotated at the cell surface, where native EDA2R is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label EDA2R as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...